Bnp Paribas Asset Management Holding S.A. United Therapeutics Corp Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in United Therapeutics Corp stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 91,117 shares of UTHR stock, worth $27.5 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
91,117
Previous 60,630
50.28%
Holding current value
$27.5 Million
Previous $18.7 Million
40.09%
% of portfolio
0.06%
Previous 0.05%
Shares
16 transactions
Others Institutions Holding UTHR
# of Institutions
730Shares Held
43.3MCall Options Held
125KPut Options Held
124K-
Black Rock Inc. New York, NY5.47MShares$1.65 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.34 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.68MShares$807 Million13.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$673 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.11MShares$635 Million1.04% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $13.7B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...